Analysis of 18 bp Ins/Del at -2549 polymorphism of the vascular endothelial growth factor gene in patients with systemic lupus erythematosus

ABSTRACT Systemic lupus erythematosus (SLE) is considered an autoimmune disease characterized by the action of autoantibodies, which cause chronic inflammation in various tissues of the body. Considering the vascular endothelial growth factor (VEGF) participation in the development of inflammation,...

Full description

Saved in:
Bibliographic Details
Main Authors: Évelin M. Cassemiro (Author), Daiani Cristina C. Alves (Author), Daniel O. Freire (Author), Lusitano B. Ferreira (Author), Carlos Eduardo C. Lins (Author), Izabel Cristina R. Silva (Author), Rodrigo Haddad (Author)
Format: Book
Published: Sociedade Brasileira de Patologia Clínica, 2017-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Systemic lupus erythematosus (SLE) is considered an autoimmune disease characterized by the action of autoantibodies, which cause chronic inflammation in various tissues of the body. Considering the vascular endothelial growth factor (VEGF) participation in the development of inflammation, this study aimed to evaluate the frequency of the polymorphism at the -2549 position (Ins/Del 18pb, rs35569394) in patients with SLE and in healthy individuals. No statistical differences were found when comparing the allele and genotype frequencies between patients and controls, suggesting that there is no association between the studied polymorphism and the development of SLE.
Item Description:1678-4774
10.5935/1676-2444.20170064